EMBRYONIC DEVELOPMENT & STEM CELL COMPENDIUM
Content
All Cell Therapies > Cell Therapy Card
Sign in for full access

Peripheral blood-derived hematopoietic stem cells for treatment of multiple sclerosis

The aim of this study is to elucidate the mechanisms of action of autologous peripheral blood-derived hematopoietic stem cell (PB-HSCs) transplantion and immunoablation by high-dose cyclophosphamide in treating multiple sclerosis (MS) patients.

No additional information regarding the therapeutic cells was provided by the sponsor.
See additional Cell Therapies for: Brain , Oligodendrocytes , Spinal Cord
Peripheral blood-derived hematopoietic stem cells for treatment of multiple sclerosis
Home
Contact Us
About Terms of Use Privacy Policy
Copyright LifeMap Sciences, Inc. - All Rights Reserved (v4.14 Build 1)
This site does not provide medical advice and is for research use only